In situ detection of hTERT variants in anaplastic large cell lymphoma

References

• Shay J W, Werbin H, Wright W E. Telomeres and telomerase in human leukaemias. Leukaemia 1996; 10: 1255–1261
   PubMed Web of Science ®Google Scholar
• Shay J W, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787–791
   PubMed Web of Science ®Google Scholar
• Nakamura T M, Morin G B, Chapman K B, Weinrich S L, Andrews W H, Lingner J, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955–959
   PubMed Web of Science ®Google Scholar
• Meyerson M, Counter C M, Eaton E N, Ellisen L W, Steiner P, Caddle S D, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785–795
   PubMed Web of Science ®Google Scholar
• Kilian A, Bowtell D D, Abud H E, Hime G R, Venter D J, Keese P K, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997; 6: 2011–2019
   PubMed Web of Science ®Google Scholar
• Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy. Oncogene 2002; 21: 688–697
   PubMed Web of Science ®Google Scholar
• Ducrest A L, Szutorisz H, Lingner J, Nabholz M. Regulation of the human telomerase reverse transcriptase gene. Oncogene 2002; 21: 541–552
   PubMed Web of Science ®Google Scholar
• Ulaner G A, Hu J F, Vu T H, Giudice L C, Hoffman A R. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 1998; 58: 4168–4172
   PubMed Web of Science ®Google Scholar
• Wick M, Zubov D, Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 1999; 232: 97–106
   PubMed Web of Science ®Google Scholar
• Colgin L M, Wilkinson C, Englezou A, Kilian A, Robinson M O, Reddel R R. The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2000; 2: 426–432
   PubMed Web of Science ®Google Scholar
• Yi X, White D M, Aisner D L, Baur J A, Wright W E, Shay J W. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2000; 2: 433–440
   PubMed Web of Science ®Google Scholar
• Norrback K F, Hultdin M, Dahlenborg K, Osterman P, Carlsson R, Roos G. Telomerase regulation and telomere dynamics in germinal centers. Eur J Haematol 2001; 67: 309–317
   PubMed Web of Science ®Google Scholar
• Norrback K F, Dahlenborg K, Carlsson R, Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996; 88: 222–229
   PubMed Web of Science ®Google Scholar
• Liu K, Schoonmaker M M, Levine B L, June C H, Hodes R J, Weng N P. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci USA 1999; 96: 5147–5152
   PubMed Web of Science ®Google Scholar
• Ohyashiki J H, Sashida G, Tauchi T, Ohyashiki K. Telomeres and telomerase in haematologic neoplasia. Oncogene 2002; 21: 680–687
   PubMed Web of Science ®Google Scholar
• Collins K, Mitchell J R. Telomerase in the human organism. Oncogene 2002; 21: 564–579
   PubMed Web of Science ®Google Scholar
• Roth A, Yssel H, Pene J, Chavez E A, Schertzer M, Lansdorp P M, et al. Telomerase levels control the lifespan of human T lymphocytes. Blood 2003; 102: 849–857
   PubMed Web of Science ®Google Scholar
• Sharma G G, Gupta A, Wang H, Scherthan H, Dhar S, Gandhi V, et al. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 2003; 22: 131–146
   PubMed Web of Science ®Google Scholar
• Roth A, Baerlocher G M, Schertzer M, Chavez E, Duhrsen U, Lansdorp P M. Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT. Blood 2005; 106: 43–50
   PubMed Web of Science ®Google Scholar
• Wu K D, Orme L M, Shaughnessy J, Jr, Jacobson J, Barlogie B, Moore M A. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood 2003; 101: 4982–4989
   PubMed Web of Science ®Google Scholar
• Kubuki Y, Suzuki M, Sasaki H, Toyama T, Yamashita K, Maeda K, et al. Telomerase activity and telomere length as prognostic factors of adult T-cell leukaemia. Leuk Lymphoma 2005; 46: 393–399
   PubMed Web of Science ®Google Scholar
• Klapper W, Krams M, Qian W, Janssen D, Parwaresch R. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation. Br J Cancer 2003; 89: 713–719
   PubMed Web of Science ®Google Scholar
• Chiu K C, Fine M, Ikle D, Slovak M L, Arber D A. Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markers. Hum Pathol 2003; 34: 1259–1264
   PubMed Web of Science ®Google Scholar
• MacNamara B, Wang W, Chen Z, Hou M, Mazur J, Gruber A, et al. Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas. Haematologica 2001; 86: 386–393
   PubMed Web of Science ®Google Scholar
• Ohshima K, Karube K, Shimazaki K, Kamma H, Suzumiya J, Hamasaki M, et al. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis. Leuk Lymphoma 2003; 44: 1339–1346
   PubMed Web of Science ®Google Scholar
• Tchirkov A, Chaleteix C, Magnac C, Vasconcelos Y, Davi F, Michel A, et al. hTERT expression and prognosis in B-chronic lymphocytic leukaemia. Ann Oncol 2004; 15: 1476–1480
   PubMed Web of Science ®Google Scholar
• Cogulu O, Kosova B, Karaca E, Gunduz C, Ozkinay F, Aksoylar S, et al. Evaluation of telomerase mRNA (hTERT) in childhood acute leukaemia. Leuk Lymphoma 2004; 45: 2477–2480
   PubMed Web of Science ®Google Scholar
• Ohyashiki J H, Hisatomi H, Nagao K, Honda S, Takaku T, Zhang Y, et al. Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and (hTR) in acute leukaemia cells. Br J Cancer 2005; 92: 1942–1947
   PubMed Web of Science ®Google Scholar
• Drummond M W, Hoare S F, Monaghan A, Graham S M, Alcorn M J, Keith W N, et al. Dysregulated expression of the major telomerase components in leukaemic stem cells. Leukaemia 2005; 19: 381–389
   PubMed Web of Science ®Google Scholar
• Falchetti M L, Pallini R, D'Ambrosio E, Pierconti F, Martini M, Cimino-Reale G, et al. In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme. Int J Cancer 2000; 88: 895–901
   PubMed Web of Science ®Google Scholar
• Pallini R, Pierconti F, Falchetti M L, D'Arcangelo D, Fernandez E, Maira G, et al. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells. J Neurosurg 2001; 94: 961–971
   PubMed Web of Science ®Google Scholar
• Wang L, Soria J C, Kemp B L, Liu D D, Mao L, Khuri F R. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. Clin Cancer Res 2002; 8: 2883–2889
   PubMed Web of Science ®Google Scholar
• Kotoula V, Barbanis S, Nikolakaki E, Koufoyannis D, Papadimitriou C S, Karkavelas G. Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas. Acta Neuropathol (Berl) 2004; 107: 443–451
   PubMed Web of Science ®Google Scholar
• Yan P, Benhattar J, Seelentag W, Stehle J C, Bosman F T. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 2004; 121: 391–397
   PubMed Web of Science ®Google Scholar
• Zaffaroni N, Della Porta C, Villa R, Botti C, Buglioni S, Mottolese M, et al. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity. J Pathol 2002; 198: 37–46
   PubMed Web of Science ®Google Scholar
• Stein H, Foss H D, Durkop H, Marafioti T, Delsol G, Pulford K, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000; 96: 3681–3695
   PubMed Web of Science ®Google Scholar
• Falini B, Pileri S, Zinzani P L, Carbone A, Zagonel V, Wolf-Peeters C, et al. ALK+ lymphoma: clinico-pathological findings and outcome. Blood 1999; 93: 2697–2706
   PubMed Web of Science ®Google Scholar
• Gascoyne R D, Aoun P, Wu D, Chhanabhai M, Skinnider B F, Greiner T C, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999; 93: 3913–3921
   PubMed Web of Science ®Google Scholar
• Drexler H G, Gignac S M, von Wasielewski R, Werner M, Dirks W G. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukaemia 2000; 14: 1533–1559
   PubMed Web of Science ®Google Scholar
• Berge R L, Oudejans J J, Ossenkoppele G J, Meijer C J. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects – a review. J Pathol 2003; 200: 4–15
   PubMed Web of Science ®Google Scholar
• Krenacs L, Wellmann A, Sorbara L, Himmelmann A W, Bagdi E, Jaffe E S, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997; 89: 980–989
   PubMed Web of Science ®Google Scholar
• Bonzheim I, Geissinger E, Roth S, Zettl A, Marx A, Rosenwald A, et al. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 2004; 104: 3358–3360
   PubMed Web of Science ®Google Scholar
• Delsol G, Ralfkiaer E, Stein H, Wright D, Jaffe E S. Anaplastic large cell lymphoma. Pathology and Genetics. Tumors of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC Press, Lyon 2001; 230–235
   Google Scholar
• Wellmann A, Otsuki T, Vogelbruch M, Clark H M, Jaffe E S, Raffeld M. Analysis of the t(2;5) (p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 1995; 86: 2321–2328
   PubMed Web of Science ®Google Scholar
• Paradis V, Bieche I, Dargere D, Bonvoust F, Ferlicot S, Olivi M, et al. hTERT expression in sporadic renal cell carcinomas. J Pathol 2001; 195: 209–217
   PubMed Web of Science ®Google Scholar
• Yi X, Shay J W, Wright W E. Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 2001; 29: 4818–4825
   PubMed Web of Science ®Google Scholar
• Kotoula V, Hytiroglou P, Pyrpasopoulou A, Saxena R, Thung S N, Papadimitriou C S. Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers. Liver 2002; 22: 57–69
   PubMedGoogle Scholar
• Kammori M, Izumiyama N, Hashimoto M, Nakamura K, Okano T, Kurabayashi R, et al. Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy. Int J Oncol 2005; 27: 1257–1263
   PubMed Web of Science ®Google Scholar
• Cerezo A, Kalthoff H, Schuermann M, Schafer B, Boukamp P. Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci 2002; 115: 1305–1312
   PubMed Web of Science ®Google Scholar
• Dhaene K, Wauters J, Weyn B, Timmermans J P, van Marck E. Expression profile of telomerase subunits in human pleural mesothelioma. J Pathol 2000; 190: 80–85
   PubMed Web of Science ®Google Scholar
• Zaffaroni N, Villa R, Pastorino U, Cirincione R, Incarbone M, Alloisio M, et al. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres. Clin Cancer Res 2005; 11: 2832–2839
   PubMed Web of Science ®Google Scholar
• Hisatomi H, Ohyashiki K, Ohyashiki J H, Nagao K, Kanamaru T, Hirata H, et al. Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene. Neoplasia 2003; 5: 193–197
   PubMed Web of Science ®Google Scholar
• NCL-TERT. Product data sheet information, available at: http://www.novocastra.co.uk/ce/gr/ccam.htm
   Google Scholar
• Santos J H, Meyer J N, Skorvaga M, Annab L A, Van Houten B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 2004; 3: 399–411
   PubMed Web of Science ®Google Scholar
• Kim J H, Park S M, Kang M R, Oh S Y, Lee T H, Muller M T, et al. Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. Genes Dev 2005; 19: 776–781
   PubMed Web of Science ®Google Scholar
• Maes B, Vanhentenrijk V, Wlodarska I, Cools J, Peeters B, Marynen P, et al. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am J Pathol 2001; 158: 2185–2193
   PubMed Web of Science ®Google Scholar
• Wellmann A, Doseeva V, Butscher W, Raffeld M, Fukushima P, Stetler-Stevenson M, et al. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1a fibroblasts. FASEB J 1997; 11: 965–972
   PubMed Web of Science ®Google Scholar
• Pulford K, Morris S W, Mason D Y. Anaplastic lymphoma kinase proteins and malignancy. Curr Opin Haematol 2001; 8: 231–236
   PubMed Web of Science ®Google Scholar
• Montgomery E, Argani P, Hicks J L, DeMarzo A M, Meeker A K. Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically. Am J Pathol 2004; 164: 1523–1529
   PubMed Web of Science ®Google Scholar
• Ulaner G A, Hoffman A R, Otero J, Huang H Y, Zhao Z, Mazumdar M, et al. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes Chromosomes Cancer 2004; 41: 155–162
   PubMed Web of Science ®Google Scholar
• Zettl A, Rudiger T, Konrad M A, Chott A, Simonitsch-Klupp I, Sonnen R, et al. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004; 164: 1837–1848
   PubMed Web of Science ®Google Scholar
• Kansal R, Sait S N, Block A W, Ward P M, Kelly F L, Cheney R T, et al. Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology. Mod Pathol 2005; 18: 235–243
   PubMed Web of Science ®Google Scholar